California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on July 6, 2026

Jul. 6, 2026

Splash Beverage Group Acquires Exclusive Global Rights to CannEpil®, an Epilepsy Therapy with Established European Patient Access, FDA Engagement and U.S. Development Potential

Indeterminate GlobeNewswire

Jul. 6, 2026

LIXTE Completes Corporate Name Change to NOMAD Power Solutions, Inc.; To Begin Trading Under New Nasdaq Symbol NMAD

Indeterminate GlobeNewswire

Jul. 6, 2026

Vivos Inc. (OTCQB: RDGL) Receives U.S. FDA Approval for Investigational Device Exemption (IDE) to Initiate Human Clinical Feasibility Study for RadioGel® Precision Radionuclide Therapy™

Indeterminate GlobeNewswire

Jul. 6, 2026

Fate Therapeutics to Present Preliminary Clinical Data of FT819 Off-the-Shelf CAR T-Cell Product Candidate for Systemic Sclerosis at the ISSCR 2026 Annual Meeting

Indeterminate GlobeNewswire

Jul. 6, 2026

QTREX Announces Operational AME System at U.S. Government Lab with a Quantum Computing Program focused on National Security

Indeterminate GlobeNewswire

Jul. 6, 2026

LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopia

Indeterminate GlobeNewswire

Jul. 6, 2026

PharmAla Completes GMP Manufacturing of Drug Substance components for ALA-002 Provides Corporate Update Regarding ALA-002 Asset

Indeterminate GlobeNewswire

Jul. 6, 2026

Clinical Service Categories Defined for Individual and Family Care

Indeterminate EIN Presswire

Jul. 6, 2026

Inspire Medical Systems, Inc. to Report Second Quarter 2026 Financial Results on July 6, 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

ThreeSixty Journalism Kicks Off Multimedia Storytelling Institute Summer Program for Local High School Students

Indeterminate GlobeNewswire

Jul. 6, 2026

GuideAI Health Appoints Renowned Interventional Radiologist Dr. James Benenati to Advisory Board Following FDA 510(k) Clearance of VAOT

Indeterminate GlobeNewswire

Jul. 6, 2026

Stress management support tops Canadian workplace needs

Indeterminate GlobeNewswire

Jul. 6, 2026

L’accompagnement en matière de gestion du stress arrive en tête des besoins des employés canadiens

Indeterminate GlobeNewswire

Jul. 6, 2026

Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer

Indeterminate GlobeNewswire

Jul. 6, 2026

Canada Diagnostic Centres, a Novacap Portfolio Company, Announces Acquisition of Shift Imaging

Indeterminate GlobeNewswire

Jul. 6, 2026

Catheter Precision, Inc. Announces Issuance of Two Key Patents

Indeterminate GlobeNewswire

Jul. 6, 2026

Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor Symposium

Indeterminate GlobeNewswire

Jul. 6, 2026

CervoMed Showcases Leadership in Advancing the Treatment and Care of Dementia with Lewy Bodies at the Alzheimer's Association International Conference (AAIC) 2026

Indeterminate GlobeNewswire

Jul. 6, 2026

TG Therapeutics Announces Initiation of Phase 2 Trial Evaluating BRIUMVI in Patients with Treatment-Resistant Schizophrenia

Indeterminate GlobeNewswire

Jul. 6, 2026

Pluristyx Inc. Secures Initial Close of Series A Priced Round with Multinational Fortune 500 Company; Round to Remain Open for Syndicate Partners Until September 2nd

Indeterminate GlobeNewswire